LLY Financial Facts

Acquired in-process research and development: 0
Cost of sales: 1.4B
See Full Income Statement

Other current liabilities: 2B
Total noncurrent liabilities: 13.7B
See Full Balance Sheet

Eli Lilly (LLY) Earnings

  |   Expand Research on LLY
Next EPS Date 4/27/21 EPS Growth Rate +26.3%
Average EPS % Beat Rate +11.5% Revenue Growth Rate +21.3%
Average % Move 1-Wk after EPS -3.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/27/21 Q121 N/A$2.21 N/A N/A$7.11B = N/A N/A
1/29/21 Q420 $2.75$2.36 +$0.39$7.44B$7.29B = Details
10/27/20 Q320 $1.54$1.71 -$0.17$5.74B$5.91B = Details
7/30/20 Q220 $1.89$1.56 +$0.33$5.5B$5.76B = Details
4/23/20 Q120 $1.75$1.48 +$0.27$5.86B$5.51B = Details
1/30/20 Q419 $1.73$1.52 +$0.21$6.11B$5.91B = Details
10/23/19 Q319 $1.48$1.40 +$0.08$5.48B$5.5B = Details
7/30/19 Q219 $1.50$1.45 +$0.05$5.64B$5.59B = Details